Panacea Pharmaceuticals has filed a U.S. patent application for Immune System Enhancing Immunotherapy for the treatment of cancer.
Founded in 1999, Panacea focuses on unmet clinical and medical needs and attempts to fill those needs with innovative, breakthrough solutions. The company specifically discovers, develops and commercializes innovative therapeutic and diagnostic products for cancer and diseases of the central nervous system.
Panacea is headquartered in the 270 Biotechnology Corridor in Maryland.
Alerts Sign-up